|
MechanismC5AR1 antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date27 Sep 2021 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date16 Jul 2021 |
A prospective, multi-center, stratified randomization, single blind, parallel, pivotal comparative clinical trial study to assess wound healing effect and safety of MTHG0808 and Collatamp®G apply to Total Mastectomy with sentinel lymph node biopsy or axillary lymph nodes dissection.
100 Clinical Results associated with Meditip Co. Ltd.
0 Patents (Medical) associated with Meditip Co. Ltd.
100 Deals associated with Meditip Co. Ltd.
100 Translational Medicine associated with Meditip Co. Ltd.